Fresenius Kabi USA LLC:企業の戦略的SWOT分析

◆英語タイトル:Fresenius Kabi USA LLC - Strategic SWOT Analysis Review
◆商品コード:SWOT20MY2895
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,125見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥26,250見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥39,375見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Fresenius Kabi USA LLC – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

Fresenius Kabi USA LLC (Fresenius Kabi), a subsidiary of Fresenius Kabi AG, is a pharmaceutical and medical device company which provides medicines and technologies for infusion, transfusion and clinical nutrition. It provides products and services to critically and chronically ill patients. The company offers injectable drugs and delivery systems, advanced transfusion medicine, cell therapy, infusion, and clinical nutrition technologies. Its products include oncology, anesthesia, analgesia, anti-infectives, parenteral nutrition, iv solutions and other critical care therapies. Fresenius Kabi provides products to hospitals, long-term care facilities, alternate care sites and clinics. It has presence in Canada and operates manufacturing and distributions units in Illinois, New York, Pennsylvania, Puerto Rico, the Dominican Republic, Mississippi and California. Fresenius Kabi is headquartered in Lake Zurich, Illinois, the US.

Fresenius Kabi USA LLC Key Recent Developments

May 15,2019: Premier’s ProvideGx subsidiary and Fresenius Kabi collaborate to address drug shortages for five critical medications

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Fresenius Kabi USA LLC – Key Facts
Fresenius Kabi USA LLC – Key Employees
Fresenius Kabi USA LLC – Key Employee Biographies
Fresenius Kabi USA LLC – Major Products and Services
Fresenius Kabi USA LLC – History
Fresenius Kabi USA LLC – Company Statement
Fresenius Kabi USA LLC – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Fresenius Kabi USA LLC – Business Description
Fresenius Kabi USA LLC – SWOT Analysis
SWOT Analysis – Overview
Fresenius Kabi USA LLC – Strengths
Fresenius Kabi USA LLC – Weaknesses
Fresenius Kabi USA LLC – Opportunities
Fresenius Kabi USA LLC – Threats
Fresenius Kabi USA LLC – Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
Fresenius Kabi USA LLC, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Fresenius Kabi USA LLC, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Fresenius Kabi USA LLC, Recent Deals Summary
Section 4 – Company’s Recent Developments
May 15, 2019: Premier’s ProvideGx subsidiary and Fresenius Kabi collaborate to address Drug Shortages for five critical medications
May 15, 2019: Premier’s ProvideGx subsidiary and Fresenius Kabi collaborate to address drug shortages for five critical medications
Section 5 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Fresenius Kabi USA LLC, Key Facts
Fresenius Kabi USA LLC, Key Employees
Fresenius Kabi USA LLC, Key Employee Biographies
Fresenius Kabi USA LLC, Major Products and Services
Fresenius Kabi USA LLC, History
Fresenius Kabi USA LLC, Other Locations
Fresenius Kabi USA LLC, Subsidiaries
Fresenius Kabi USA LLC, Key Competitors
Fresenius Kabi USA LLC, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Fresenius Kabi USA LLC, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Fresenius Kabi USA LLC, Recent Deals Summary

List of Figures
Fresenius Kabi USA LLC, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Fresenius Kabi USA LLC, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Fresenius Kabi USA LLC:企業の戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Perpetual Limited (PPT):企業の財務・戦略的SWOT分析
    Perpetual Limited (PPT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Protagen Protein Services GmbH-製薬・医療分野:企業M&A・提携分析
    Summary Protagen Protein Services GmbH (PPS), a subsidiary of Zukunftsfonds Heilbronn GmbH & Co KG is a contract research organization that concentrates on protein analytics. The organization offers services including protein characterization, services for biopharmaceuticals, biosimilars services an …
  • Standard Chem & Pharm Co Ltd:企業の戦略・SWOT・財務情報
    Standard Chem & Pharm Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Standard Chem & Pharm Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Chaman Lal Setia Exports Ltd:企業の戦略・SWOT・財務分析
    Chaman Lal Setia Exports Ltd - Strategy, SWOT and Corporate Finance Report Summary Chaman Lal Setia Exports Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Enerplus Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Enerplus Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Enerplus Corp (Enerplus), formerly Enerplus Resources Fund is an oil and gas company that offers exploration and development services. The company provides exploration and development of natural resour …
  • Opus Energy Group Ltd:企業の戦略的SWOT分析
    Opus Energy Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • AB Science SA (AB):製薬・医療:M&Aディール及び事業提携情報
    Summary AB Science SA (ABS) is a pharmaceutical company focused on discovery, development, and commercialization of protein kinase inhibitors. The company's lead compound Masitinib, is a orally administered tyrosine kinase inhibitor targeting mast cells and selected kinases, including c-Kit, PDGFR, …
  • Dicerna Pharmaceuticals Inc (DRNA):企業の財務・戦略的SWOT分析
    Summary Dicerna Pharmaceuticals Inc (Dicerna) is a biopharmaceutical company that offers therapies. The company discovers and develops treatments for rare inherited diseases including liver and for cancers that are genetically defined. It offers RNAi technology platform GalXCTM, which is a advances …
  • Sinochem Group Co Ltd:企業の戦略的SWOT分析
    Sinochem Group Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Trustpower Limited (TPW)-エネルギー分野:企業M&A・提携分析
    Summary TrustPower Limited (Trustpower) is an energy utility that retails electricity, gas and telecommunication services. The company produces electricity from wind, hydro, and diesel sources. It owns and operates various power projects across New Zealand and Australia. Trustpower also leases elect …
  • South Texas Accelerated Research Therapeutics:製薬・医療:M&Aディール及び事業提携情報
    Summary South Texas Accelerated Research Therapeutics (START) accelerates the development of novel anticancer agents that improves personalized and clinical care for cancer patients. The company offers preclinical and clinical research services which include pharmacokinetics, in vivo and in vitro se …
  • CryoLife Inc (CRY)-医療機器分野:企業M&A・提携分析
    Summary CryoLife Inc (CryoLife) is a provider of biosurgical devices and implantable living tissues for cardiac and vascular surgical procedures. The company’s portfolio encompasses preserved human cardiac allografts, vascular allografts, surgical adhesives and sealants, heart valves, carbon dioxide …
  • ImmunoGen Inc (IMGN):医療機器:M&Aディール及び事業提携情報
    Summary ImmunoGen Inc (ImmunoGen) is a clinical-stage biotechnology company that focuses on the development of antibody-drug conjugate therapies for the treatment of cancer. The company’s lead product candidate, mirvetuximab soravtansine, a folate receptor alpha (FRa) intended for the treatment of p …
  • Indianapolis Power & Light Co:企業の戦略的SWOT分析
    Indianapolis Power & Light Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Toyo Kanetsu K.K.:企業の戦略・SWOT・財務情報
    Toyo Kanetsu K.K. - Strategy, SWOT and Corporate Finance Report Summary Toyo Kanetsu K.K. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Gree Inc (3632):企業の財務・戦略的SWOT分析
    Gree Inc (3632) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Ricoh Co Ltd (7752):企業の財務・戦略的SWOT分析
    Ricoh Co Ltd (7752) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • First Light Biosciences Inc:企業の製品パイプライン分析2018
    Summary First Light Biosciences Inc (FLB) is a medical device company that develops and manufactures automated medical diagnostic products for the detection of healthcare associated infections. The company’s product includes multipath analyzer system. Its multipath analyzer system detects resistant …
  • Pt Bank Central Asia Tbk
    Pt Bank Central Asia Tbk - Strategy, SWOT and Corporate Finance Report Summary Pt Bank Central Asia Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • CapeRay Medical (Pty) Ltd:製品パイプライン分析
    Summary CapeRay Medical (Pty) Ltd (CapeRay), formerly African Medical Imaging is a medical device company that offers imaging solutions. The company offers breast imaging devices. It offers aceso system to detect breast cancer with standard digital mammography. CapeRay’s aceso system is used for det …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆